Details for New Drug Application (NDA): 065208
✉ Email this page to a colleague
NDA 065208 describes CEFPROZIL, which is a drug marketed by Apotex Inc, Aurobindo Pharma, Chartwell Rx, Lupin, Orchid Hlthcare, Ranbaxy Labs Ltd, Sandoz, Alkem Labs Ltd, Teva, and Wockhardt, and is included in sixteen NDAs. It is available from seven suppliers. Additional details are available on the CEFPROZIL profile page.
The generic ingredient in CEFPROZIL is cefprozil. There are thirteen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the cefprozil profile page.
The generic ingredient in CEFPROZIL is cefprozil. There are thirteen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the cefprozil profile page.
Suppliers and Packaging for NDA: 065208
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| CEFPROZIL | cefprozil | TABLET;ORAL | 065208 | ANDA | Teva Pharmaceuticals USA, Inc. | 0093-1077 | 0093-1077-01 | 100 TABLET, FILM COATED in 1 BOTTLE (0093-1077-01) |
| CEFPROZIL | cefprozil | TABLET;ORAL | 065208 | ANDA | Teva Pharmaceuticals USA, Inc. | 0093-1078 | 0093-1078-53 | 50 TABLET, FILM COATED in 1 BOTTLE (0093-1078-53) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 250MG | ||||
| Approval Date: | Dec 6, 2005 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 500MG | ||||
| Approval Date: | Dec 6, 2005 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
